-
Drug Development in Rare Diseases: Focus on Clinical Trials and the Regulatory Landscape Published: January, 2021 - Pages: 107 - US$ 3,950.00
-
Selective Estrogen Receptor Degrader (SERDs) Market, Dosage, Price & Clinical Trials Insight 2025 Published: January, 2021 - Pages: 120 - US$ 2,400.00 COVID-19 update included[CovidUpdated]
-
Global KRAS Inhibitors Market Opportunity & Clinical Trials Outlook 2025 Published: January, 2021 - Pages: 125 - US$ 2,000.00 COVID-19 update included[CovidUpdated]
-
Burns Disease - Global Clinical Trials Review, H2, 2020 Published: December, 2020 - Pages: 291 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Delirium Disease - Global Clinical Trials Review, H2, 2020 Published: December, 2020 - Pages: 296 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Dermatitis (Eczema) Disease - Global Clinical Trials Review, H2, 2020 Published: December, 2020 - Pages: 1071 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Emesis (Vomiting) Disease - Global Clinical Trials Review, H2, 2020 Published: December, 2020 - Pages: 308 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Tetanus Disease - Global Clinical Trials Review, H2, 2020 Published: December, 2020 - Pages: 276 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Fibromyalgia (Fibromyalgia Syndrome) Disease - Global Clinical Trials Review, H2, 2020 Published: December, 2020 - Pages: 307 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Use of Artificial Intelligence in Pharmaceutical Drug Development and Clinical Trials: Case Study Published: January, 2021 - Pages: 64 - US$ 495.00 COVID-19 update included[CovidUpdated]